刘婷婷

文章来源: 发布时间:2022-09-02浏览次数:

 

姓名:刘婷婷

职称:校聘副教授,硕士生导师

联系邮箱:liutingting@sdfmu.edu.cn; 15853121615@163.com

课题组主页:http://www.x-mol.com/groups/tina-liu

 

学习经历:

2009.09~2013.06        延边大学药学院药学,学士

2013.09~2018.12        山东大学药学院药物化学,硕博连读

2017.11~2018.11    UT Southwestern Medical Center化学生物学,访问学者

 

工作经历:

2019.09~至今    山东第一医科大学药学院药物化学,校聘副教授

 

研究方向:

1. 靶向肿瘤小分子荧光探针的设计、合成及评价研究

2. 靶向肿瘤的小分子抑制剂的设计、合成及评价研究

 

主要学术任职:

1. 山东生物医学工程学会医美药分子工程专业委员会委员

2. J. Med. Chem., Eur. J. Med. Chem.等期刊审稿人

 

主要获奖情况:

1. 山东省课程思政示范案例三等奖山东省高等医学教育研究中心,2021

2. 于金明科技创新奖山东第一医科大学,2021

 

主要科研课题:

1. 国家自然科学基金青年基金项目8210131454,新型BRD4荧光探针的构建及其在乳腺癌成像分析中的应用研究,2022.01-2024.1230万元,主持

2. 山东省自然科学基金青年项目ZR2020QH344新型环境敏感型 Mcl-1 荧光探针的设计、合成及成像应用研究2021.01-2023.1214万元,主持。

3. 山东省医药卫生科技发展计划项目2019WS393,新型环境敏感型Mcl-1荧光探针的设计、合成及生物成像应用研究,2020.06-2022.062万元,主持。

 

近五年代表性论文(限第一作者和通讯作者)

1. Tingting Liu*, Shubin Song, Xu Wang, Jifu Hao. Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer. European Journal of Medicinal Chemistry, 2021, 210, 112954. (IF = 7.0)

2. Zheng Zhang#, Xiaolan Xing#, Peng Guan, Shubin Song, Guirong You, Chengcai Xia, Tingting Liu*. Recent progress in agents targeting polo-like kinases: Promising therapeutic strategies. European Journal of Medicinal Chemistry, 2021, 217, 113314. (IF = 7.0)

3. Sitao Zhang, Yanzhao Chen, Chengsen Tian, Yujing He, Zeru Tian, Yichao Wan and Tingting Liu*. Dual-target inhibitors based on BRD4: Novel therapeutic approaches for cancer. Current Medicinal Chemistry, 2021, 28, 1775-1795

4. Tingting Liu*, Yichao Wan, Yuliang Xiao, Chengcai Xia, Guiyun Duan. Dual-target inhibitors based on HDACs: Novel antitumor agents for cancer therapy. Journal of Medicinal Chemistry, 2020, 63, 8977-9002. (IF = 8.0)

5. Tingting Liu*, Zhongyu Wu, Yujing He, Yuliang Xiao, Chengcai Xia. Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy. European Journal of Medicinal Chemistry, 2020, 201, 112446-112458. (IF = 7.0)

6. Yichao Wan*, Chunxing Yan, Han Gao, Tingting Liu*. Small-molecule PROTACs: Novel agents for cancer therapy. Future Medicinal Chemistry, 2020, 12, 1756-8919.

7. Tingting Liu, Gaopan Dong, Feng Xu, Bowen Han, Hao Fang, YunHuang, Yubin Zhou, Lupei Du, Minyong Li*. Discovery of turn-On fluorescent probes for detecting Bcl-2 Protein. Analytical Chemistry, 2019, 91, 5722-5728. (IF = 8.0)

8. Tingting Liu, Yuqi Gao, Xiaomeng Zhang, Yichao Wan, Lupei Du, Hao Fang, Minyong Li*. Discovery of a turn-On fluorescent probe for myeloid cell leukemia1 protein. Analytical Chemistry, 2017, 89, 11173-11177. (IF = 8.0)

9. Tingting Liu, Yichao Wan, Renshuai Liu, Lin Ma, Minyong Li, Hao Fang*. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors. Bioorganic & Medicinal Chemistry, 2017, 25, 1939-1948. 

10. Tingting Liu#, Yan Jiang#, Zhenzhen Liu, Jin Li, Kun Fang, Chunlin Zhuang, Lupei Du, Hao Fang, Chunquan Sheng* and Minyong Li*. Environment-sensitive turn-on fluorescent probes for p53-MDM2 protein-protein interaction. MedChemComm, 2017, 8, 1727-1732.

 

上一篇:​刘培庆

下一篇:何玉静

版权所有:山东第一医科大学(山东省医学科学院)药学院(药物研究所)   鲁ICP备19027497号-1